Abstract. There is argument whether non-sedative properties of histamine H 1 -receptor antagonists (antihistamines) are determined by their active extrusions from the brain via P-glycoprotein or their restricted penetration through the blood-brain barrier. We have reported that sedative and non-sedative antihistamines can be well discriminated by measuring changes in their binding to H 1 receptors upon receptor internalization in intact cells, which depends on their membranepenetrating ability. In this study, molecular determinants responsible for sedative and non-sedative properties of antihistamines were evaluated by quantitative structure-activity relationship (QSAR) analyses. Multiple regression analyses were applied to construct a QSAR model, taking internalization-mediated changes in the binding of antihistamines as objective variables and their structural descriptors as explanatory variables. The multiple regression model was successfully constructed with two explanatory variables, i.e., lipophilicity of the compounds at physiological pH (logD) and mean information content on the distance degree equality (IDDE) (r 2 = 0.753). The constructed model discriminated between sedative and non-sedative antihistamines with 94% accuracy for external validation. These results suggest that logD and IDDE concerning lipophilicity and molecular shapes of compounds, respectively, predominantly determine the membranepenetrating ability of antihistamines for their side effects on the central nervous system.
Introduction
Histamine H 1 -receptor antagonists / inverse agonists (antihistamines) are well known to have side effects such as sedation, hypnosis, and cognitive impairment, which are associated with the blockade of H 1 receptors in the central nervous system (CNS). On the basis of these clinical side effects, antihistamines are generally divided into two groups, i.e., sedative and non-sedative (or less sedative) antihistamines. Non-sedative antihistamines have fewer side effects on the CNS as a result of less blockade of H 1 receptors in the CNS, although they might induce sedation at higher doses. It is yet still inconclusive, however, about whether non-sedative properties of antihistamines are determined by their active extrusion from the brain via P-glycoprotein (1 -3) or their restricted penetration through the blood-brain barrier (4 -7) .
Receptor internalization, movement of the receptor from the cell surface to intracellular compartments, is known to affect the binding properties of receptor ligands in intact cells, depending on their ability to penetrate the biomembrane (8, 9) . We therefore tested how receptor internalization influenced the binding properties of a variety of antihistamines under ice-cold conditions where a P-glycoprotein-mediated extrusion pump might not work (10) . Our finding is that there are clear differences between the effect of H 1 -receptor internalization on the binding of sedative and non-sedative antihistamines to intact cells, which provide strong evidence that simple diffusion through the plasma membrane predominantly determines their sedative and non-sedative properties. However, the variety of chemical structures and physicochemical properties of antihistamines makes it difficult
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to accurately predict membrane-penetrating ability for their sedative and non-sedative properties.
Quantitative analyses of the chemical structures of compounds can be useful to explain and predict their effects on physiological functions (11) : many studies on quantitative structure-activity relationships (QSAR) have been successful in the analyses and prediction of pharmacological effects (12) , enzymatic activities (13), affinities for receptor proteins (14) , pharmacokinetic parameters (15) , and drug metabolism (16) . However, there is no report concerning a QSAR model specifically designated for the membrane-penetrating ability of antihistamines; therefore, we tried to establish a QSAR model to explain and predict membrane-penetrating ability of antihistamines for their sedative and non-sedative properties on the basis of our previous report (10) .
Here we show that sedative and non-sedative properties of antihistamines can be predicted with extremely high accuracy by the QSAR model constructed on the basis of their membrane-penetrating ability alone. To our knowledge, we succeeded for the first time in constructing a QSAR model to explain and predict sedative and non-sedative properties of antihistamines, and the constructed QSAR model may also contribute to optimizing the development of novel antihistamines with respect to their side effects on the central nervous system.
Materials and Methods

Training and external validation set of antihistamines assessed
Nineteen antihistamines, for which the internalizationmediated changes in their binding to intact cells are already known (10) , were assessed as a training set of antihistamines ( Fig. 1) : sedative antihistamines were chlorpheniramine, clemastine, cyproheptadine, diphenhydramine, mepyramine, promethazine, azelastine, ketotifen oxatomide, ebastine, loratadine, and terfenadine (12 compounds) and non-sedative antihistamines were mequitazine, epinastine, bepotastine, carebastine, fexof- enadine, desloratadine, and olopatadine (7 compounds). The non-sedative behavior of ebastine, loratadine, and terfenadine is considered to be due to their corresponding active metabolites, carebastine, desloratadine, and fexofenadine, respectively (10) .
Sixteen antihistamines, for which the internalizationmediated changes in their binding to intact cells are unknown, were assessed as an external validation set of antihistamines ( Fig. 2) : sedative antihistamines were alimemazine, azatadine, dimetindene, diphenylpyraline, homochlorcyclizine, hydroxyzine, imipramine, isothipendyl, and triprolidine (9 compounds) and non-sedative antihistamines were acrivastine, astemizole, cetirizine, emedastine, levocabastine, mizolastine, and temelastine (7 compounds).
Objective variables for assessment of sedative and nonsedative properties of antihistamines
As an objective variable to assess the sedative and non-sedative properties of antihistamines, the extent of changes in the binding of a training set of 19 antihistamines by internalization of H 1 receptors was expressed as the difference in area under the curve (AUC) between the displacement curves obtained with histamine-pretreated (i.e., internalization-induced) and histamine-non-pretreated control cells (DAUC, Fig. 3 ). Briefly, cells were pretreated with or without 0.1 mM histamine for 30 min at 37°C in HEPES buffer (120 mM NaCl, 5.4 mM KCl, 1.6 mM MgCl 2 , 1.8 mM CaCl 2 , 11 mM d-glucose, and 25 mM HEPES, pH 7.4 at 37°C) to induce the internalization of H 1 receptors. Subsequently, the cells were washed with ice-cold HEPES buffer and intact cell binding was performed at 4°C as described in our previous paper (9, 10) . The displacement curves were fitted to either a one-or two-site model as follows (KaleidaGraph; Synergy Software, Reading, PA, USA); One-site model in the experiment without histamine pretreatment: B1 cont = 100 − (P × C) / (IC cont + C) One-site model in the experiment with histamine pretreatment: B1 his = 100 − (P × C) / (IC his + C) Two-site model in the experiment without histamine pretreatment:
, where B1 cont , B1 his , B2 cont , and B2 his are the amounts of bound [ 3 H]mepyramine (taking radioactivity in the absence of antihistamines as 100% in each set of experiments); P is the percentage of the binding of antihistamines; C is the concentration of antihistamines used; IC his and IC cont are the IC 50 values for antihistamines in cells with or without histamine pretreatment, respectively; P H and P L are percentages of high and low affinity sites for antihistamines, respectively; IC contH and IC contL are IC cont values for antihistamines at high and low affinity sites, respectively; IC hisH and IC hisL are IC his values for antihistamines at high and low affinity sites, respectively. DAUC for each antihistamine in the training set was calculated as follows:
where DAUC1 was defined as DAUC introduced from B1 cont and B1 his in the one-site model; DAUC2 was defined as DAUC introduced from B2 cont and B2 his in the two-site model.
Descriptors as explanatory variables for DAUC
Chemical structures of antihistamines were collected in the "SMILES" format from the NCBI PubChem compound database. Three-dimensional structures were constructed by "clean 3D function, process for energy optimization of 3D structures" in Marvin View ver. 5.3.2 (ChemAxon, Ltd., Budapest, Hungary) from the SMILES files. Geometries of the 3D structures were refined and optimized by MMFFaq force field in Spartan 08 ver. 1.1.1. (Wavefunction, Inc., Irvine, CA, USA). Molecular descriptors of antihistamines were calculated from their optimized 3D structures by Dragon software ver. 5.5 (Talete srl, Milano, Italy). The Dragon descriptors of 1593 types were used in the present study. Lipophilicity of the compounds at pH 7.5 (logD) was calculated by a tautomer-considered KLOP method in arvinView.
Construction and application of simple and multiple regression models
The Dragon descriptors and logD values were used to construct simple and multiple regression models in the training set. The best model was explored by genetic algorithms (17) with the leave-one-out cross validation (18) as a selection pressure of the model using MobyDigs ver 1.1 (Talete srl); that is, the determination coefficient in the leave-one-out method (Q 2 loo) was used as an index of predictive performance in the model. The predictive performance in the model was validated by the prediction of bootstrapping samples of compounds in the training set. Finally, the constructed model was applied to predict sedative and non-sedative antihistamines in the external validation set.
Regression diagnosis
Regression diagnosis and other statistical analyses of the prediction models were performed by JMP ver. 8.0.2 (SAS Institute, Inc., Cary, NC, USA).
Results
DAUC as an objective variable for assessment of sedative and non-sedative properties of antihistamines
In the training set, sedative and non-sedative antihistamines were successfully discriminated using experimentally-obtained DAUC values with a value of approximately 20 arbitrary units (Table 1 and Fig. 4) .
Simple regression analyses
Simple regression analyses (SRA) showed that logD had the most significant correlation with DAUC values for antihistamines in the training set and DAUC values predicted by logD were as follows (Table 1): SRA-predicted DAUC = -(9.87 ± 2.02)logD + (44.2 ± 6.1) A significant relationship between DAUC values obtained experimentally and predicted by the above equation was also confirmed ( Fig. 5a ; n = 19, r 2 = 0.584). Using this equation, sedative and non-sedative antihistamines in the external validation set were discriminated with 75% accuracy at the value of 20 arbitrary units of SRA-predicted DAUC ( Fig. 6a; 12 of 16 antihistamines).
Multiple regression analyses
In multiple regression analyses (MRA), combinatorial optimization of the descriptors was performed to explain the variance of DAUC by a genetic algorithm with an adequate number of trials. As a result, a regression formula with the maximal determination coefficient in the leave-one-out cross-validation (Q 2 loo) was constructed as below, and a more significant relationship was observed between DAUC values obtained experimentally and predicted in MRA than in SRA (n = 19, Values of DAUC, logD, and IDDE for antihistamines were obtained as described in Materials and Methods. AUC, area under the curve; logD, lipophilicity of the compounds at pH 7.5; IDDE, the mean information content on distance degree equality; SRA, simple regression analyses; MRA, multiple regression analyses.
no correlation between logD and IDDE was observed (VIF = 1). Regression diagnosis with the residual plot, plotting for the predicted DAUC value and the residual in the prediction of each antihistamine, revealed no specific abnormalities in the present model. More specifically, the residuals were almost normally distributed, and no skewness was found in the plot. Using the above equation with a combination of logD and IDDE, sedative and non-sedative antihistamines in the external validation set were discriminated with 94% accuracy at the value of 20 arbitrary units of MRApredicted DAUC (Fig. 6b, 15 of 16 antihistamines) .
Discussion
Discrimination between sedative and non-sedative antihistamines by DAUC
DAUC values were evaluated as quantitative parameters to represent changes in the binding of antihistamines to H 1 receptors upon receptor internalization, which were considered to simply represent their membrane-penetrating ability (10) . In the training set of antihistamines, sedative and non-sedative antihistamines were clearly discriminated by DAUC at the arbitrary unit of 20. Thus, DAUC appeared to be a very promising objective criterion for constructing a QSAR model to predict sedative and non-sedative properties of antihistamines.
Simple regression analyses
It is known that logD is one of the physicochemical descriptors related with the biomembrane permeability of drugs (19) . Accordingly, of the various types of explanatory descriptors, the logD value was best correlated with DAUC; however, logD alone did not fully discriminate between sedative and non-sedative antihistamines in our assessment, as reported by others (20) . This suggests that logD is important, but not adequate, for determination of the sedative and nonsedative properties of antihistamines; therefore, multiple regression models with plural descriptors were required to improve the predictability of the sedative effects of antihistamines.
Multiple regression analyses
The number of subjects is one of the most important factors to regulate the attribute number in multiple regression models because excess attribute numbers will likely result in a chance correlation. The number of attributes chosen in the construction process should be as small as possible in order to prevent a chance correlation. A systematic study suggested that the number of available descriptors in a multiple regression equation to maintain the predicting performance is 2, when the number of subjects is less than 20 compounds (21) . Since the number of antihistamines in the training set was 19, the number of descriptors was restricted to 2 in this model. Variable selection was performed using the genetic algorithm approach, and the leave-one-out method was adopted as a validation system for the generalization capability of the model constructed (18) . As a result, IDDE as well as logD were selected in the QSAR model. IDDE is a descriptor related to molecular shape, which is based on atomic networks in a molecule 74. This finding of apparent improvement in the statistical property compared to the case of simple regression with logD or IDDE alone suggests that IDDE is an important parameter that enhances the prediction accuracy with logD. More specifically, it is presumed that spurious decorrelation between IDDE and DAUC was found by statistical adjustment of logD as a confounder.
Thus, the constructed multiple regression model achieved a high level of prediction performance for the external validation set of antihistamines. It is noted that the constructed model indicated non-sedative properties of dimetindene, although dimetindene is classified as a first-generation of antihistamine. In good accordance with this, there are evidences that dimetindene is as non-sedative as loratadine (23, 24) . Furthermore, the constructed model well predicted non-sedative properties of bilastine (25), a newly-developed antihistamine, with a predicted DAUC value of 45.7 arbitrary units. Thus, the model is expected to have good generalization capability to predict sedative effects on a variety of seed compounds for antihistamines.
Simple diffusion as determinant of sedative and nonsedative properties of antihistamines
Since the model constructed is mainly based on extrapolations from in vitro studies on cells, there is a possibility that the predictability can be affected by factors such as transporters to regulate absorption, distribution, metabolism, and excretion of antihistamines in vivo. Actually, the rank order of sedative and nonsedative properties of antihistamines, which was evaluated by positron emission tomography (PET) by use of [ 11 C]doxepin in vivo (26), was not entirely identical but mostly compatible with our results: some discrepancies observed might be explained, at least in part, by the fact that the receptor occupancy by antihistamines in the brain varied according to their doses administrated (27) , which resulted in changes in the rank order of their sedative and non-sedative properties in vivo (26) . Thus, the assertion that sedative and non-sedative properties of antihistamines can be predominantly determined by their membrane-penetrating ability rather than their extrusion from the brain via P-glycoproteins is strengthened by the results that the QSAR model constructed on the basis of their membrane penetrating ability alone discriminated almost perfectly between sedative and non-sedative antihistamines. Furthermore, it is revealed that the two descriptors concerning their lipophilicity and molecular shapes, logD and IDDE, respectively, are involved in physicochemical properties of antihistamines to determine their membrane-penetrating ability for their side effects on the CNS.
Scope of application of this QSAR model
The prediction model was constructed for antihistamines in the training set. Although antihistamines have a wide range of diverse structures and physicochemical properties, the fundamental structure is to fit the binding cavity on H 1 -receptor proteins. Accordingly, prediction for an external validation set of antihistamines with different chemical structures resulted in extremely good performance with the constructed model. Since it is generally considered that the QSAR prediction model should not be used for assessment using a deviant structure from the structural diversity used in the model construction, it appears that this prediction model might be restricted in application to compounds fitting the binding cavity on H 1 receptors.
Conclusion
We constructed a QSAR model to predict the sedative and non-sedative properties of antihistamines with high accuracy, which indicated that molecular parameters concerning their lipophilicity and molecular shapes determines their membrane-penetrating ability for their side effects on the CNS. Although a variety of antihistamines have been developed so far, development of novel antihistamines such as bilastine is still in progress. Together with the recent findings of the crystal structure of the human H 1 receptor and differential binding sites of first and second generations of antihistamines responsible for their H 1 -receptor specificity (28) , the constructed QSAR model may contribute to develop novel or even further generation of antihistamines with increased specificity to H 1 receptors and reduced side effects on the CNS.
